1154331

Salil U. Nadkarni, DO — FEI 3020134804

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 24, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Los Angeles, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance